Vapotherm Inc at William Blair Growth Stock Conference Transcript
Good afternoon, everyone, and welcome to the William Blair Growth Stock Conference. My name is Marga Kaczor. I am the research analyst here at William Blair & Company who covers Vapotherm. I'm required to inform you that you can obtain a complete list of research disclosures or potential conflicts of interest at williamblair.com.
Now with us today, we're pleased to have CFO, John Landry; as well as CTO, Brian Lawrence. Vapotherm, just as a little bit of a background, it's one of those stocks that I think gotten pushed into this COVID beneficiary category. And COVID ultimately did end up accelerating a lot of their growth.
However, for us, the reason you want to own this story, you want to look into this story is that it's positioning to be much bigger than that.
For us, we look for platform names at William Blair, trying to go from the small cap, mid cap, and large cap. And today even though Vapotherm primarily sells its high-velocity VNI Technology, which competes with traditional ventilators in the hospital, as you look over the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
